pheochromocytoma
PHEOCHROMOCYTOMA
Pheochromocytoma is a rare adrenal gland tumor that may precipitate life-threatening hypertension.
It can occur at any age but usually occurs during young to mid-adult life.
Majority of patients presents with ≥1 of the following hypertension resistant to standard antihypertensive treatment, hypertensive crisis with malignant hypertension, hypertensive encephalopathy, aortic dissection, or myocardial infarction and paroxysmal symptoms which suggest seizure disorder, anxiety attacks or hyperventilation.

Pheochromocytoma Treatment

Pharmacotherapy

Alpha-Adrenergic Blockade

  • First-line therapy used to minimize complications prior to surgery

Phenoxybenzamine

  • Action: Powerful irreversible alpha-adrenergic blocker of the alpha receptors in the smooth muscles
  • Effects: Oral administration results in an onset of action w/in a few hr & persists for up to 3-4 days
    • Used to control the hypertension caused by excessive catecholamine release by pheochromocytoma

Selective Alpha1-Antagonists

  • Eg Doxazosin
  • Action: Selective blockade of alpha1-adrenoreceptors
  • Effects: Limited use in pheochromocytoma, Phenoxybenzamine is more effective
  • May be used to treat individual paroxysms
  • May also may be used to treat hypertension while pheochromocytoma workup is ongoing
    • Better tolerated than Phenoxybenzamine
    • Prevent serious pressor crisis if pheochromocytoma is present

Beta-Blockers

  • Eg Propranolol, Atenolol
  • Administer only after alpha blockade has been induced
    • W/o alpha blockade paradox increase in BP may occur
  • Action: Competitive antagonists of catecholamines at beta-adrenergic receptors
  • Effects: Used to treat tachycardia that may develop w/ alpha blockade
    • Assist in preventing catecholamine-induced arrhythmias
  • Low doses are usually sufficient

Calcium Channel Blockers

  • Eg Nifedipine, Amlodipine
  • Used as add-on treatment to alpha-adrenergic receptor blockers to further improve cardiovascular function peri-operatively
  • Action: Blocks slow calcium channels to prevent calcium ion flow into the cell
  • Effects: Vasodilatation, reduced afterload, peripheral resistance & blood pressure

Metirosine (Metyrosine)

  • Action: Inhibits tyrosine hydroxylase which inhibits synthesis of catecholamines by the tumor
  • Effects: Simplifies chronic management
  • Should be used if other agents are ineffective or when tumor destruction will be marked
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 May 2020
This second issue revisits the impact EMPA-REG OUTCOME had on clinical practice and helps readers discover how it gives life back to patients through its cardiovascular indication. Learn how it was approved and the possible mechanisms for its cardiovascular benefits.
Stephen Padilla, 22 Jul 2019
Zinc supplementation significantly lowers key glycaemic indicators, particularly fasting glucose (FG) in individuals with diabetes and in those who received an inorganic supplement, results of a systematic review and meta-analysis have shown.
Elaine Soliven, 15 Oct 2020

Higher levels of exercise appear to be associated with a lower risk of all-cause mortality in adults with type 2 diabetes (T2D) compared with no exercise at all, according to a study presented at EASD 2020.